Stay updated on Elacestrant in ER+ Advanced Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page; the content appears unchanged.
    Difference
    0.1%
    Check dated 2025-10-30T19:54:39.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    38 days ago
    Change Detected
    Summary
    Upgrade notice to v3.2.0 with a government-operating-status disclaimer; removal of v3.0.2 indicates the version update.
    Difference
    2%
    Check dated 2025-10-02T02:28:42.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page has updated the EMERALD trial entry with a new Phase 3 record dated 2025-09-15, replacing the previous 2024-10-30 version. Core trial details (design, endpoints, eligibility, arms) are retained but refreshed; minor wording and date formats updated. If no significant content changes beyond the update, note that this is an updated trial record rather than a new conceptual change.
    Difference
    3%
    Check dated 2025-09-25T01:10:38.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Version bumped to v3.0.1 and a Back to Top link added. The previous version tag v3.0.0-post.1-g752effb-HEAD has been removed.
    Difference
    0.1%
    Check dated 2025-09-10T18:15:22.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated to a new version, v3.0.0-post.1-g752effb-HEAD, indicating a revision in the content.
    Difference
    0.0%
    Check dated 2025-09-03T14:48:48.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of numerous locations and the introduction of Elacestrant, a new treatment for advanced breast cancer. Several previous locations and medications have been removed, indicating a shift in focus and content relevance.
    Difference
    16%
    Check dated 2025-08-27T10:36:20.000Z thumbnail image

Stay in the know with updates to Elacestrant in ER+ Advanced Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elacestrant in ER+ Advanced Breast Cancer Clinical Trial page.